IGHE and Alzheimer disease: The results obtained in this study demonstrated that compound 2 could improve the symptoms of the AD through inhibiting the release of Th2 cytokines IL-4, 5 and 17 as well as suppressing the activation of mast cells via suppressing the synthesis of IgE.